Conference Reports for NATAP

EASL 2024 June 5-8, Milan, Italy Back

A prospective, blinded, multicenter U.S. evaluation of a multi-analyte blood-based test for the detection of hepatocellular carcinoma (HCC) in patients with cirrhosis       EASL 2024 June 5-8 Milan Italy   Richard Van Etten (US)